Stockscreener 앱 받기
0.6598
0.00%
0.00
전일 마감가:
$0.6598
열려 있는:
$0.7
하루 거래량:
371.38K
Relative Volume:
0.19
시가총액:
$7.23M
수익:
-
순이익/손실:
$-9.64M
주가수익비율:
-0.0953
EPS:
-6.9236
순현금흐름:
$-10.11M
1주 성능:
+1.60%
1개월 성능:
-28.33%
6개월 성능:
-76.77%
1년 성능:
-76.01%
1일 변동 폭
$0.68
$0.71
1주일 범위
$0.62
$0.7124
52주 변동 폭
$0.54
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
명칭
Gt Biopharma Inc
전화
(800) 304-9888
주소
505 MONTGOMERY STREET, SAN FRANCISCO
GTBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.34 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.57 | 303.77M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.16 | 221.34M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.7287 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.98 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | ROTH MKM | Buy |
| 2021-05-24 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | B. Riley Securities | Buy |
| 2021-03-17 | 개시 | ROTH Capital | Buy |
Gt Biopharma Inc 주식(GTBP)의 최신 뉴스
GT Biopharma Inc Stock Analysis and ForecastEarnings Surprise Analysis & Free Get High Impact Recommendations - earlytimes.in
GT Biopharma Inc OXIA Stock Analysis and ForecastStraddle and Strangle Trades & Free High Yield Portfolio Picks - earlytimes.in
Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com
GT Biopharma, Inc. Reports Continued Progress with Its Phase 1 Clinical Trial of GTB-3650 - marketscreener.com
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market - The Manila Times
What is GT Biopharma Inc (GTBP) Stock Return on Shareholders’ Capital? - setenews.com
GT Biopharma (GTBP) Stock Analysis Report | Financials & Insights - Benzinga
Why GT Biopharma Inc. (OXIA) stock could rally stronglyJuly 2025 Recap & Daily Price Action Insights - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - KamloopsBCNow
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points (2025-12-04) - Seeking Alpha
What technical charts say about GT Biopharma Inc. stockTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
What is the fair value estimate for GT Biopharma Inc. (OXIA) stock in 2025July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
The growth track for GT Biopharma Inc (GTBP) has changed recently - Setenews
What Wall Street predicts for GT Biopharma Inc. stock priceTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Is GT Biopharma Inc. (OXIA) stock a buy on weaknessWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
How supply chain issues affect GT Biopharma Inc. stockRate Hike & Consistent Income Trade Ideas - Newser
How reliable is GT Biopharma Inc. (OXIA) stock dividend growthWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
What drives GT Biopharma Inc stock priceShort Interest Overview & Superior Trading Portfolio - earlytimes.in
GT Biopharma faces Nasdaq bid-price deficiency, eyes compliance options - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: GT Biopharma Inc (GTBP) - Setenews
GT Biopharma shares advance as flagship GTB 3650 trial escalates to next dose level - MSN
GT Biopharma (GTBP) Price Target Decreased by 27.27% to 8.16 - MSN
How GT Biopharma Inc. (OXIA) stock responds to job market shiftsMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Is GT Biopharma Inc. (OXIA) stock a fit for income portfoliosPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
Will GT Biopharma Inc. (OXIA) stock extend growth storyWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com
Will GT Biopharma Inc. (OXIA) stock deliver compounding returns2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Is GT Biopharma Inc. stock attractive for income investorsWatch List & Stepwise Entry and Exit Trade Signals - newser.com
Developing predictive dashboards with GT Biopharma Inc. dataChart Signals & Daily Entry Point Alerts - newser.com
Is GT Biopharma Inc. trending in predictive chart models2025 Price Targets & Weekly Stock Breakout Alerts - newser.com
Will GT Biopharma Inc. bounce back from current supportQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com
Is GT Biopharma Inc. (OXIA) stock positioned for secular growth2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Tools to monitor GT Biopharma Inc. recovery probabilityMarket Risk Report & Real-Time Market Trend Scan - newser.com
GT Biopharma stock rises as Phase 1 trial advances to higher dose - Investing.com Nigeria
GT Biopharma stock rises as Phase 1 trial advances to higher dose By Investing.com - Investing.com South Africa
Gt Biopharma Inc (GTBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
1.23%
자본화:
|
볼륨(24시간):